AJP - Endo AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E584-E591, 2003; doi:10.1152/ajpendo.00140.2003
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majumdar, G.
Right arrow Articles by Solomon, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majumdar, G.
Right arrow Articles by Solomon, S. S.

O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon

Gipsy Majumdar,1 Ashley Harmon,1,7 Rosalind Candelaria,1,7 Antonio Martinez-Hernandez,1,3,5 Rajendra Raghow,1,6 and Solomon S. Solomon1,2,4,6

1Research, 2Medical and 3Pathology Services, Veterans Affairs Medical Center, Memphis 38104; and Departments of 4Medicine, 5Pathology, and 6Pharmacology, and 7College of Medicine, University of Tennessee, the Health Science Center, Memphis, Tennessee 38163

Submitted 31 March 2003 ; accepted in final form 21 May 2003

Both insulin and glucagon stimulate steady-state levels of Sp1 transcription factor, but only insulin stimulates transcription of the calmodulin (CaM) gene in liver. Because O-glycosylation of Sp1 by O-linked N-acetylglucosamine (O-GlcNAc) is thought to regulate its ability to activate transcription, we assayed the levels of Sp1 with anti-Sp1 and anti-O-GlcNAc antibodies in Western blots by use of extracts of H-411E liver cells treated with insulin (10,000 µU/ml) or glucagon (1.5 x 10-5 M). We also assessed subcellular localization of the native and glycosylated Sp1 in H411E cells treated with either hormone in the presence of deoxynorleucine (DON, an indirect inhibitor of O-glycosylation) or streptozotocin (STZ, an indirect stimulator of O-glycosylation). Insulin stimulated both total and O-GlcNAc-modified Sp1 primarily in the nucleus and induced CaM gene transcription (P < 0.0001). In contrast, glucagon promoted accumulation of Sp1 in the cytoplasm but not the nucleus, without significantly stimulating (P = not significant) either its O-glycosylation or transcription of the CaM gene. DON inhibited O-glycosylation of Sp1 and its ability to migrate to the nucleus and transactivate CaM gene transcription. In contrast, cotreatment of cells with STZ and glucagon enhanced O-glycosylation of Sp1, promoting its migration to the nucleus and resulting in increased CaM gene transcription. Thus O-glycosylation of Sp1 by insulin, but not glucagon, apparently enhances its (Sp1) nuclear recruitment and results in activation of CaM gene transcription.

Sp1 transcription factor; calmodulin gene transcription; liver cells; diabetes mellitus



Address for reprint requests and other correspondence: S. Solomon, Research Services (151), 1030 Jefferson Ave., Memphis, TN 38104 (E-mail: ssolomon{at}utmem.edu).




This article has been cited by other articles:


Home page
GlycobiologyHome page
N. Noach, Y. Segev, I. Levi, S. Segal, and E. Priel
Modification of Topoisomerase I Activity by Glucose and by O-Glcnacylation of the Enzyme Protein
Glycobiology, December 1, 2007; 17(12): 1357 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. A. Sacksteder, J. E. Whittier, Y. Xiong, J. Li, N. A. Galeva, M. E. Jacoby, S. O. Purvine, T. D. Williams, M. C. Rechsteiner, D. J. Bigelow, et al.
Tertiary Structural Rearrangements upon Oxidation of Methionine145 in Calmodulin Promotes Targeted Proteasomal Degradation
Biophys. J., August 15, 2006; 91(4): 1480 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Vij and P. L. Zeitlin
Regulation of the ClC-2 Lung Epithelial Chloride Channel by Glycosylation of SP1
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Ye, D. Shedd, and G. Miller
An Sp1 Response Element in the Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50 Promoter Mediates Lytic Cycle Induction by Butyrate
J. Virol., February 1, 2005; 79(3): 1397 - 1408.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Majumdar, J. Wright, P. Markowitz, A. Martinez-Hernandez, R. Raghow, and S. S. Solomon
Insulin Stimulates and Diabetes Inhibits O-Linked N-Acetylglucosamine Transferase and O-Glycosylation of Sp1
Diabetes, December 1, 2004; 53(12): 3184 - 3192.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.